Revenue: As of FY2025 Q2, the actual value is USD 3.24 B, beating the estimate of USD 3.222 B.EPS: As of FY2025 Q2, the actual value is USD 0.7, missing the estimate of USD 0.9175.EBIT: As of FY2025 Q2, the actual value is USD 121 M.<h3>Global Distribution and Value-Added Services</h3><ul><li>Net Sales: $2,731 million for Q2 2025, an increase of 2.9% from $2,654 million in Q2 2024.</li><li>Operating Income: $159 million for Q2 2025, a decrease from $176 million in Q2 2024.</li><li>Gross Margin: 25.2% for Q2 2025, down from 26.4% in Q2 2024.</li></ul><h3>Global Specialty Products</h3><ul><li>Net Sales: $386 million for Q2 2025, an increase of 4.2% from $370 million in Q2 2024.</li><li>Operating Income: $52 million for Q2 2025, up from $40 million in Q2 2024.</li><li>Gross Margin: 54.9% for Q2 2025, slightly down from 55.5% in Q2 2024.</li></ul><h3>Global Technology</h3><ul><li>Net Sales: $167 million for Q2 2025, an increase of 7.4% from $156 million in Q2 2024.</li><li>Operating Income: $45 million for Q2 2025, up from $34 million in Q2 2024.</li><li>Gross Margin: 67.9% for Q2 2025, up from 67.6% in Q2 2024.</li></ul><h3>Cash Flow</h3><ul><li>Operating Cash Flow: $157 million for the six months ended June 28, 2025, compared to $493 million for the same period in 2024.</li><li>Free Cash Flow: Not explicitly stated, but net cash used in investing activities was $197 million, and net cash provided by financing activities was $145 million for the six months ended June 28, 2025.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company is focusing on integrating recent acquisitions and increasing efficiencies through the 2024 restructuring plan, with expected charges through the end of 2025.</li><li>Non-Core Business: The company is assessing the impact of the One Big Beautiful Bill Act (OBBBA) on its financial statements, which includes changes to corporate tax rates and Medicaid funding.</li></ul>

Henry Schein | 10-Q: FY2025 Q2 Revenue Beats Estimate at USD 3.24 B